Publicaciones RedinRen

• The value of serum free light chain assay in patients with monoclonal gammopathies and renal failure.

  Campos, ML; Barbosa-de Carvalho, NM; Martín-Reyes, G.. Nefrologia. 2012;32(1):15-19.

• Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma

  Martín-Reyes, G; Toledo-Rojas, R; Torres-de Rueda, Á; Sola-Moyano, E; Blanca-Martos, L; Fuentes-Sánchez, L; Martínez-Esteban, MD; Díez-de los Ríos, MJ; Bailén-García, A; González-Molina, M; García-González, I.. Nefrologia. 2012;32(1):35-43.

• Survival and factors predicting mortality in hemodialysis patients over 75 years old.

  Oliva, JS; Roa, LM; Lara, A; Garrido, S; Salgueira, M; Palma, A; Milán, JA; Martín-Reyes, G.. J Nephrol. 2013;26(1):129-135.

• Endocrine alterations and cardiovascular risk in CKD: is there a link?

  Ros, S; Carrero, JJ.. Nefrologia. 2013;33(2):181-187.

• Increased risk of fatal infections in women starting peritoneal dialysis.

  Ros, S; Remón, C; Qureshi, AR; Quiros, P; Lindholm, B; Carrero, JJ.. Perit Dial Int. 2013;33(5):487-494.

• PERITONEAL RESTING WITH HEPARINIZED LAVAGE REVERSES PERITONEAL TYPE I MEMBRANE FAILURE. A COMPARATIVE STUDY OF THE RESTING EFFECTS ON NORMAL MEMBRANES.

  De Sousa-Amorim, E; Del Peso, G; Alvarez, L; Ros, S; Mateus, A; Aguilar, A; Selgas, R; Bajo Rubio, MA.. Perit Dial Int. 2014;.

• Perception of health and understanding of cardiovascular risk among patients with recently diagnosed diabetes and/or metabolic syndrome.

  Martell-Claros, N; Aranda, P; González-Albarrán, O; Dalfó-Baqué, A; Domínguez-Sardiña, M; de la Cruz, JJ; Campo, C; de Álvaro, C.. Eur J Prev Cardiol. 2013;20(1):21-28.

• The development of anemia is associated to poor prognosis in NKF/KDOQI stage 3 chronic kidney disease.

  Portolés, J; Gorriz, JL; Rubio, E; de Alvaro, F; García, F; Alvarez-Chivas, V; Aranda, P; Martinez-Castelao, A; NADIR-3 Study Group.. BMC Nephrol. 2013;14:2.

• A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs.

  Darbà, J; Kaskens, L; Aranda, P; Arango, C; Bobes, J; Carmena, R; Rejas, J.. Ann Clin Psychiatry. 2013;25(1):17-26.

• SureClick® (Darbepoetin alfa) can improve perceived satisfaction and competence for anemia treatment and increase self-administration in non-dialyzed patients with chronic kidney disease.

  Bonafont, X; Romero, R; Martínez, I; del Pino, MD; Gil, JM; Aranda, P; Roca, R; Claverol, J; Cucala, M; Grupo del Estudio Preference.. Nefrologia. 2013;33(2):214-222.

• Spanish Society of Nephrology document on KDIGO guidelines for the assessment and treatment of chronic kidney disease.

  Gorostidi, M; Santamaría, R; Alcázar, R; Fernández-Fresnedo, G; Galcerán, JM; Goicoechea, M; Oliveras, A; Portolés, J; Rubio, E; Segura, J; Aranda, P; de Francisco, AL; Del Pino, MD; Fernández-Vega, F; Górriz, JL; Luño, J; Marín, R; Martínez I; Martínez-Castelao, A; Orte, LM; Quereda, C; Rodríguez-Pérez, JC; Rodríguez, M; Ruilope, LM.. Nefrologia. 2014;34(3):302-316.

• Donors deceased according to cardiocirculatory criteria (Maastricht 3) with livers valid for transplantation

  Daga-Ruiz, D; Frutos-Sanz, MA; Segura-González, F; Lebrón-Gallardo, M; Pérez-Vacas, J; Muñoz-Muñoz, JL.. Med Intensiva. 2014;.

• Continuously evaluating performance in deceased donation: the Spanish quality assurance program.

  de la Rosa, G; Domínguez-Gil, B; Matesanz, R; Ramón, S; Alonso-Álvarez, J; Araiz, J; Choperena, G; Cortés, JL; Daga, D; Elizalde, J; Escudero, D; Escudero, E; Fernández-Renedo, C; Frutos, MA; Galán, J; Getino, MA; Guerrero, F; Lara, M; López-Sánchez, L; Macías, S; Martínez-Guillén, J; Masnou, N; Pedraza, S; Pont, T; Sánchez-Rodríguez, A.. Am J Transplant. 2012;35(5):2507-2513.

• Associated characteristics and impact on survival of post renal-transplantation lymphoproliferative disease: case-control study from a regional registry.

  Gentil Govantes, MA; Vidal Blandino, M; Ruiz Esteban, P; Rodelo Haad, C; Torrado Masero, J; Toro Ramos, M; Burgos Rodríguez, D; Alonso Gil, M; Osuna Ortega, A; Franco Esteve, A.. Transplant Proc. 2013;45(10):3624-3626.

• High incidence of delayed graft function in HIV-infected kidney transplant recipients.

  Mazuecos, A; Fernandez, A; Zarraga, S; Andres, A; Rodriguez-Benot, A; Jimenez, C; Gomez, E; Paul, J; Jimeno, L; Fernandez, C; Burgos, D; Sanchez-Fructuoso, A; Guirado, L.. Transpl Int. 2013;26(9):893-902.

• Renal-pancreas transplant: prognosis of the pancreas after technical failure of the kidney

  Aranda-Narváez, JM; Pérez-Daga, JA; Cabello-Díaz, M; Blanco-Reina, F; Santoyo-Santoyo, J. Cir Esp. 2012;90(10):672-674.

• Transplant Glomerulopathy: Clinical course and factors relating to graft survival

  Lopez, V; Fuentes, L; Jimenez, T; Leon, M; Garcia, I; Sola, E; Cabello, M; Gutierrez, C; Burgos, D; Ruiz, P; Hernandez, D. Trasnplantation Proceedings. 2012;44:2599-2600.

• Survival of Lopus Nephritis Patients after Renal Transplantation in Malaga

  Fuentes, L; Hernandez, D; Ruiz,P; Blanca, L; Lopez, V; Sola, E; Gutierrez, C; Cabello, M; Burgos, D; Gonzalez-Molina, M; Fernandez-Nebro, A.. Trasnplantation Proceedings. 2012;44:2067-2068.

• Renal replacement therapy in patients with HIV infection in a European Region: Outcomes following renal transplantation.

  Mazuecos, A; Rodriguez-Benot, A; Moreno, A; Burgos, D; Aguera, M; Garcia-Alvarez, T; Hernandez, D; Navarro, D; Castro,P.. Transplantation Proceedings. 2012;44:1053-2056.

• Rate of Long-term Graft Loss has fallen among Kidney Transplants from Cadaveric Donors

  Burgos, D; Gonzalez-Molina, M; Ruiz-Esteban, P; Gutierrez, C; Rodriguez, MA; Fuentes, L; Blanca, L; Hernandez, D. Transplantation Proceedings. 2012;44:1558-2560.

• Optimization of Expanded Donors Using Dual Kidney Trasnplantation: Case-Control Study

  Frutos, MA; Mansilla, JJ; Cabello, M; Soler, J; Ruiz, P; Lebron, M; Baena, V; Hernandez, D.. Transplantation Proceedings. 2012;44:2060-2062.

• Optimización de donantes expandidos con el trasplante birrenal: estudio caso-control

  Frutos, MA; Mansilla, JJ; Cabello, M; Soler, J; Ruiz, P; Lebron, M; Baena, V; Hernandez, D. Nefrologia. 2012;32(3):306-312.

• Mycophenolate Mofetil and Tacrolimus Reduce Mortality After Deceased Donor Kidney Transplantation

  Gonzalez-Molina, M; Ruiz-Esteban, P; Burgos, D; Rodriguez, MA; Cabello, M; Gutierrez, E; Hernandez D. Transplantation Proceedings. 2012;44:2577-2578.

• Concordance of Estimated Glomerular Filtration Rates Using Cockcroft-Gault, Modification of Diet in Renal Disease, and Chronic Kidney Disease Epidemiology in Renal Transplant Recipients.

  Ruiz-Esteban, P; Lopez, V; Garcia-Frias, P; Cabello, M; Gonzalez-Molina M; Vozmediano, C; Hernandez, D. Transplantation Proceedings. 2012;44:2561-2563.

• Cardiovascular Risk in Recipients with Kidney Transplants from Expanded Criteria Donors

  Blanca, L; Jimenez, T; Cabello, M; Sola, E; Gutierrez, C; Burgos, D; Lopez, V; Hernandez, D. Transplantation Proccedings. 2012;44:2579-2581.

• Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population

  Hernandez, D; Espejo-Gil, A; Bernal-Lopez, MR; Mancera-Romero, J; Baca-Osorio, AJ; Tinahones, FJ; Armas-Padron, AM; Ruiz-Esteban, P; Torres, A; Gomez-Huelgas, R. BMC Nephrology. 2013;14:151.

• Clinical Assessment of Mortality Risk in Renal Transplant Candidates in Spain

  Hernandez, D; Castro de la Nuez, P; Muriel, A; Ruiz-Esteban, P; Gonzalez-Molina, M; Burgos, D; Cabello, M; Luengo, S; Palma, E; Rudas, E; Gutierrez, E; Vozmediano, C; Torres, A; Alonso, M.. TRANSPLANTATION. 2014;98:653-659.

• Decrease in the percentage of peripheral blood CXCR3highCD4+ lymphocytes after renal transplantation

  Caballero, A; Ruiz-Esteban, P; Palma, E; Ramirez, P; Fuentes, L; Sola, E; Rudas, E; Alonso, A; Hernandez, D.. Transplant Immunology. 2014;31:7-10.

• Impact of immunosuppression treatment on the improvement in graft survival after deceased donor renal transplantation: a long-term cohort study.

  Gonzalez-Molina, M; Burgos, D; Cabello, M; Ruiz-Esteban, P; Rodriguez, MA; Gutierrez, C; Lopez, V; Baena, V; Hernandez, D.. NEFROLOGIA. 2014;34(5):570-578.

• Regression of cardiac growth in kidney transplant recipients using anti-m-TOR drugs plus RAS blockers: a controlled longitudinal study.

  Hernandez, D; Ruiz-Esteban, P; Gaitan, D; Burgos, D; Mazuecos, A; Collantes, R; Briceño, E; Palma, E; Cabello, M; Gonzalez-Molina, M; De Mora, M.. BMC Nephrology. 2014;15:65.

• Longitudinal observational studies and causality.

  Muriel A, Hernández-Marrero D, Abraira V. Nefrologia. 2012;32(1):12-4.

• High doses of irbesartan offer long-term kidney protection in cases of established diabetic nephropathy.

  Ros-Ruiz S, Aranda-Lara P, Fernández JC, Martínez-Esteban MD, Jironda C, Hidalgo P. Nefrologia. 2012;32(2):187-96.

• Renal sympathetic denervation: a new treatment strategy in the management of refractory arterial hypertension.

  Aranda-Lara P, Martínez-Esteban MD, Muñoz JJ, Hernández-Marrero D. Nefrologia. 2012;32(5):555-7.

• Role of renal sympathetic denervation in a refractory arterial hypertension patient.

  Martínez-Esteban MD, Aranda-Lara P, Muñoz J, Toledo-Rojas R, Sola-Moyano E, Torres-Rueda Á. Nefrologia. 2012;32(5):670-3.

• Impact of blood amylase peak over vascular graft thrombosis in pancreas transplantation.

  Montiel-Casado MC, Fernández-Burgos I, Pérez-Daga JA, Aranda-Narváez JM, Sánchez-Pérez B, González-Sánchez AJ. Transplant Proc. 2012 Nov;44(9):2627-30.

• Kidney transplantation with grafts from type III Maastricht non-beating-heart donors.

  Frutos-Sanz MÁ, Guerrero-Gómez F, Daga-Ruiz D, Cabello-Díaz M, Lebrón-Gallardo M, Quesada-García G. Nefrologia. 2012;32(6):760-6.

• The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.

  Goyache-Goñi B, Aranda-Lara P, Reyes-Engels A, Frutos-Sanz MA, Hernández-Marrero D. Nefrologia. 2013 Nov 13;33(6):771-8.

• Pancreas graft survival in simultaneous pancreas-kidney versus pancreas-after-kidney and pancreas alone transplantations: a single institution experience.

  Montiel-Casado MC, Pérez-Daga JA, Aranda-Narváez JM, Fernández-Burgos I, Sánchez-Pérez B, León-Díaz FJ. Transplant Proc. 2013 Dec;45(10):3609-11.